Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...

This virtual public workshop provided a venue for stakeholders to examine bottlenecks to innovation in drug research and development (R&D) for prevalent chronic diseases and to highlight opportunities ...

The goal of this collaborative is to examine and highlight the bottlenecks to drug research and development (R&D) for highly prevalent chronic diseases and develop a set of key considerations and ...

Texas Biomedical Research Institute has established a new $2 million Tuberculosis Innovation and Technology Fund supported by philanthropic investment to accelerate future TB discoveries, therapies ...

For Western pharmaceutical leaders, the question is no longer whether to engage Asia, but how to integrate its capabilities ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. In a move that could dramatically reshape the landscape for rare ...

Expanded portfolio offerings include first-to-market product launches to support global health challenges New infectious disease research solutions to be spotlighted at ASM Microbe 2025 CORALVILLE, ...

Massimo Radaelli, PhD, is a European pharmaceutical industry leader and entrepreneur who has devoted more than 30 years to the innovation of therapies to treat rare diseases. He is President and CEO ...

Under the theme "Nurturing Innovation at Its Source", this intellectual gathering served as a platform for cross-sector collaboration, while also witnessed the official launch of the Clicklinks ...

The FDA has recently approved multiple veterinary drugs targeting conditions from pain and inflammation to parasitic infections, reflecting rapid innovation in animal health. Advances include novel ...

Your editorial on “Why Vinay Prasad Had to Go at FDA” should be a wake-up call for anyone who cares whether federal bureaucrats get to decide if promising new medicines are available to desperately ...

Participation in state AIDS Drug Assistance Programs was associated with improved HIV treatment outcomes and high rates of viral suppression.